All Articles: Research

Carrie Haskell-Luevano

Dr. Carrie Haskell-Luevano loves being a researcher. As a professor and Philip S. Portoghese Endowed Chair in Chemical Neuroscience, she finds joy in teaching students and making discoveries alongside her laboratory staff. Read about the value she finds in her partnership with UMN Technology Commercialization.

Mark Schneiderhan

Pharmacists can help keep tabs on the overall health of those with mental illnesses.

David Stenehjem

David Stenehjem works in the rapidly growing field of outcomes research, which guides his research on midostaurin in FLT3-mutated acute myeloid leukemia.

Laura Palombi headshot

Federal grants are helping the U collaborate with rural partners to focus on strengthening community resources to prevent addiction and create healthy environments for those working toward recovery.

Doctor Ahmar U. Zaidi

Ahmar U. Zaidi, MD, Medical Director, Clinical Development, Sickle Cell Disease Program at Agios Pharmaceuticals presented "The Sickle Caste: From a Single Mutation to Victimization and the Road Back".

Patient being examined by an Optometrist

The results of Phase 2 clinical trials for glaucoma drug QLS-101 have demonstrated a favorable safety and tolerability profile, according to a news release by Qlaris Bio, which licensed the drug in 2019. A positive efficacy signal was also reported.

Dr. Daniel Harki Headshot

The Midwest Antiviral Drug Discovery (AViDD) Center is part of a network of nine national centers established in response to the public health emergency.

Calvin Sun Headshot

Goal of new center is to transform the way pharmaceutical drugs are formulated and manufactured.

Gold and maroon university of minnesota flags

The College of Pharmacy has worked in collaboration with the Center for Allied Health Programs (CAHP), the Academic Health Sciences, and the Provost’s office to move the CAHP into the College of Pharmacy.

Abdullah Al Noman and Gunda I. Georg Headshots

At the recently held spring meeting of the American Chemical Society (ACS), research findings were presented on a non-hormonal pill that could soon expand birth control options for men.